MARKETSLupin Signs US Licensing Deal for Cancer Biosimilar; Shares End FlatDhruva KulkarniDecember 4, 2025December 4, 2025 December 4, 2025December 4, 2025 Shares of Lupin Ltd ended flat on 4th December, even though the firm said it has signed an exclusive licensing agreement with US-based Valorum Biologics...
MARKETSLupin Falls 2% After USFDA Issues OAI for Pithampur Unit 2Dhruva KulkarniOctober 6, 2025October 6, 2025 October 6, 2025October 6, 2025 Shares of Lupin Ltd fell 2% on 6th October after touching a day’s high of Rs 1,972.90. This occurred as the company announced that the...
MARKETSLupin Shares Trading Flat as Unit Acquires VISUfarma for Rs 1,970 CroreDhruva KulkarniSeptember 29, 2025September 29, 2025 September 29, 2025September 29, 2025 Shares of Lupin Ltd are trading flat after touching a day’s high of Rs 1,958 on 29th September, even as the company announced that its...
MARKETSLupin Shares End 3% Higher on USFDA Nod for Schizophrenia, Bipolar Disorder DrugDhruva KulkarniSeptember 3, 2025September 3, 2025 September 3, 2025September 3, 2025 Shares of Lupin Ltd ended 3% higher after hitting a day’s high of Rs 1,953.80 on 3rd September, following the company’s announcement that it has...